Phase Ib Trial Comparing Different Doses and Schedules of a Folate-Binding Protein-Derived Peptide Vaccine, E39, and its Attenuated Version, E39', to Induce Long-Term Folate-Binding Protein-Specific Immunity in Disease-Free Cancer Patients
Jackson, Doreen O., MD, Vreeland, Timothy, MD, Hale, Diane F., MD, Greene, Julia M., MD, Berry, John S., MD, Trappey, Alfred F, Hardin, Mark O., MD, Clifton, Guy T., MD, FACS, Peoples, George E., MD, FACS, Mittendorf, Elizabeth A., MD, PhD, FACS
Published in Journal of the American College of Surgeons (01.10.2016)
Published in Journal of the American College of Surgeons (01.10.2016)
Get full text
Journal Article